Enzalutamide‐induced severe thrombocytopenia complicated by a seizure in a 76‐year‐old man with castration‐resistant prostate cancer

INTRODUCTION: Adverse events with enzalutamide widely used for men with castration‐resistant prostate cancer are of interest. CASE PRESENTATION: A 76‐year‐old man developed castration‐resistant prostate cancer. He received 160 mg of enzalutamide daily. On the 13th day after treatment, severe thrombo...

Descripción completa

Detalles Bibliográficos
Autores principales: Murata, Masaki, Takizawa, Itsuhiro, Maruyama, Ryo, Kasahara, Takashi, Hara, Noboru, Tomita, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292079/
https://www.ncbi.nlm.nih.gov/pubmed/32743361
http://dx.doi.org/10.1002/iju5.12025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292079/
https://www.ncbi.nlm.nih.gov/pubmed/32743361
http://dx.doi.org/10.1002/iju5.12025

Ejemplares similares